Form D — Ancilia Biosciences, Inc.
0001975776-26-000006 · filed Apr 6, 2026
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Other filings
Offering
- Industry
- Other
- Exemptions
- Rule 506(b)
- Reported offering amount
- $10,076,464
- Reported amount sold
- $10,076,464
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ancilia Biosciences, Inc.
- CIK
- 1975776
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 3960 BROADWAY, 6TH FLOOR
NEW YORK, New York 10032 - Phone
- 716-474-6710
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
ALEXANDRA SAKATOS · Executive OfficerLONG ISLAND CITY, New York Find on LinkedIn ↗
-
RODOLPHE BARRANGOU · Executive OfficerLONG ISLAND CITY, New York Find on LinkedIn ↗
-
DALE PFOST · DirectorLONG ISLAND CITY, New York Find on LinkedIn ↗
-
VERA SCHROEDER · DirectorLONG ISLAND CITY, New York Find on LinkedIn ↗
-
GURDANE BHUTANI · DirectorLONG ISLAND CITY, New York Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗